Long-term study of an experimental drug for stable schizophrenia
Part of Mental health clinical trials.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and living in Japan
- You have a diagnosis of schizophrenia and have been stable for at least 8 weeks
- Your symptoms are mild to moderate (a total score of 80 or less on the PANSS scale and a CGI-S score of 4 or less)
- You have not changed your antipsychotic medication in the last 6 weeks
- You have not been in the hospital for psychiatric reasons in the last 8 weeks
- You have not tried multiple antipsychotics that did not work for you, and you have never taken clozapine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called SEP-363856 for people with schizophrenia who are currently having a severe flare-up of symptoms. It aims to see if the drug is safe and effective compared to a placebo.
This study tests a new medicine called NBI-1117568 for adults with schizophrenia over a longer period of time. Participants will stop their current antipsychotics and take this new drug to see how well it works and how safe it is.
This trial tests a new drug, ML-007C-MA, for adults with schizophrenia who may benefit from ongoing treatment. It aims to see how safe and effective the drug is over a longer period.
This study tests the long-term safety of an investigational medication for schizophrenia over one year. It may be an option if you are currently stable on your antipsychotic medication.
This study gives healthy men a single dose of a drug with a tiny amount of radioactivity to see how it leaves the body through urine and stool. It helps researchers understand how the drug is processed.
This trial tests a new combination pill (xanomeline/trospium) for people who started treatment for schizophrenia in the last 5 years, to see if it helps better than their current medicine. You would stop your current antipsychotic and switch to this study drug under close doctor supervision.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.